News

29.08.2018

ImaginAb and CPDC announce clinical trial supply manufacture and distribution agreement for ImaginAb’s CD8 immuno PET tracer

21.08.2018

Neon Therapeutics appoints Jolie M. Siegel as General Counsel

09.08.2018

Jounce Therapeutics reports second quarter 2018 financial results

08.08.2018

Tracon Pharmaceuticals reports second quarter 2018 financial results and provides corporate update

06.08.2018

Kura Oncology reports second quarter 2018 financial results and provides corporate update

06.08.2018

Neon Therapeutics reports second quarter 2018 financial results and recent business highlights

02.08.2018

Jounce Therapeutics to announce second quarter 2018 financial results and host conference call on Thursday, August 9, 2018

01.08.2018

Blueprint Medicines reports second quarter 2018 financial results

01.08.2018

Blueprint Medicines to present at upcoming investor conferences in August

01.08.2018

Tracon Pharmaceuticals to report second quarter 2018 company highlights and financial results on August 8, 2018

31.07.2018

Kura Oncology appoints Marc Grasso, M.D., as Chief Financial Officer and Chief Business Officer

30.07.2018

Kura Oncology to report second quarter 2018 financial results

25.07.2018

Blueprint Medicines to report second quarter 2018 financial results on Wednesday, August 1, 2018

18.07.2018

Revolution Medicines Sanofi and Revolution Medicines launch global partnership to develop potential first-in-class targeted treatments for multiple cancers

09.07.2018

ImaginAb appoints James Allison, Padmanee Sharma and Ramy Ibrahim to scientific advisory board

02.07.2018

Kura Oncology announces closing of public offering and full exercise of option to purchase additional shares

29.06.2018

Neon Therapeutics announces closing of initial public offering

28.06.2018

Kura Oncology announces pricing of USD 67 million public offering of common stock

27.06.2018

Kura Oncology announces commencement of public offering of common stock

26.06.2018

Neon Therapeutics announces pricing of initial public offering

Events

Past Events

14.05. – 16.05.2018

19TH ANNUAL BIO€QUITY EUROPE
Ghent, Belgium

26.02. – 27.02.2018

11th Annual European Life Sciences CEO Forum & Exhibition
Zurich, Switzerland

08.01. – 11.01.2018

J.P. Morgan 36th Annual Healthcare Conference
San Francisco, USA

09.12. – 12.12.2017

59th ASH Annual Meeting
Atlanta, USA

28.11. – 29.11.2017

BioFIT 2017
Strasbourg, France

Keep me updated about investment opportunities in the area of oncology and life sciences.

Latest Newsletters

September 2018 June 2018 April 2018 October 2017 May 2017 February 2017

Sitemap Sitemap

Nextech Invest Ltd.Turnerstrasse 26, 8006 Zurich, Switzerland P +41 (0)44 366 66 11 F +41 (0)44 366 66 10Privacy Policy

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

* Compulsory fields

Newsletter Registration

Your eMail have been successfully registered.

This website uses cookies to provide you with the best possible service. By using our website, you consent to the use of cookies in accordance with our privacy policy. Here you can find out more.